Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania.
Tudor Olariu,Rodica Lighezan,Sorin Ursoniu,Alina Cristiana Craciun,Ana Alexandra Paduraru,Maria Alina Lupu +5 more
TLDR
In this paper, the authors evaluated the prevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania and found that the overall seroprevalence was 1.51%.About:
This article is published in Clinical Microbiology and Infection.The article was published on 2021-01-06 and is currently open access. It has received 8 citations till now. The article focuses on the topics: Seroprevalence & ABO blood group system.read more
Citations
More filters
Journal ArticleDOI
Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic.
TL;DR: In this paper, the seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors in Jordan, at various points of time and as the pandemic evolves in the community, were studied.
Posted ContentDOI
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review
Sahar Saeed,Samra Uzicanin,Antoine Lewin,Ryanne W. Lieshout-Krikke,Helen Z. M. Faddy,Christian Erikstrup,Carla Osiowy,Clive R. Seed,Whitney R. Steele,Katy Davidson,Brian Custer,Sheila F. O'Brien +11 more
TL;DR: This article conducted a scoping review of peer-reviewed and pre-print publications between January 2020 and January 2021, focusing on severe acute respiratory syndrome coronavirus 2 seroprevalence studies conducted among blood donors to investigate methodological biases and provide guidance for future research.
Journal ArticleDOI
SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India
Srinivasa Rao Chunchu,Ushasree Ravula,Vikram Kumar Gente,S. Bacchu,S. Pandu Ranga Rao,Srujaleswari Mooli +5 more
TL;DR: In this article , the authors aimed to estimate the seroprevalence of SARS-CoV-2 IgG (S-protein) antibodies along with neutralizing assay (RBD-domain) among the whole blood donors without any prior Covid-19 history or symptoms visiting Blood Centre at a tertiary care institution, South India amidst the ongoing pandemic.
Posted ContentDOI
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic
Maher A. Sughayer,Asem Mansour,Abeer Al Nuirat,Lina Souan,Mohammad Ghanem,Mahmoud Siag,Sallam Alhassoon +6 more
TL;DR: In this paper, the seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors in Jordan, at various points of time as the pandemic evolves in the community.
Journal ArticleDOI
The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020
Corina Manolea,andrei capitanescu,Roxana Georgiana Borș,Ioana Rugescu,melihan bechir,Claudia Mehedintu,Valentin Nicolae Varlas +6 more
TL;DR: In this article, the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in triage-negative patients undergoing ART and fertility care providers after lockdown release and throughout 2020 was investigated.
References
More filters
Journal ArticleDOI
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.
Janko Nikolich-Zugich,Kenneth S. Knox,Carlos Tafich Rios,Bhupinder Natt,Deepta Bhattacharya,Mindy J. Fain +5 more
TL;DR: The virus, its structure and evolution, epidemiology and pathogenesis, immunogenicity and immune, and clinical response in older adults are reviewed, using available knowledge on SARS-CoV-2 and its highly pathogenic relatives MERS- coV and Sars- CoV-1.
Journal ArticleDOI
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
Ali Rostami,Mahdi Sepidarkish,Mariska M.G. Leeflang,Seyed Mohammad Riahi,Malihe Nourollahpour Shiadeh,Sahar Esfandyari,Ali H. Mokdad,Peter J. Hotez,Robin B. Gasser +8 more
TL;DR: A meta-analysis to estimate the global and regional SARS-CoV-2 seroprevalence rates in humans, and to assess whether serop revalence associates with geographical, climatic and socio-demographic factors, suggested an association with income, human development and climate change.
Journal ArticleDOI
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
Luiz Amorim Filho,Célia Landmann Szwarcwald,Sheila de Oliveira Garcia Mateos,Antonio Ponce de Leon,Roberto de Andrade Medronho,Valdilea G. Veloso,Josiane Iole França Lopes,Luís Cristóvão Porto,Alexandre Chieppe,Guilherme Loureiro Werneck +9 more
TL;DR: The findings comply with some basic premises: the increasing trend over time, as the epidemic curve in the state is still on the rise; and the higher prevalence among both the youngest, for moving around more than older age groups, and the less educated, for encountering more difficulties in following social distancing recommendations.
Journal ArticleDOI
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.
TL;DR: Seroprevalence of IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 3,186 regular blood donors in three German federal states between 9 March and 3 June 2020 was determined.
Journal ArticleDOI
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan.
TL;DR: The seroprevalence of SAR-CoV-2 antibodies, its clinical significance and to identify if total antibodies(IgA, IgM, IgG) should be tested or just the specific IgG antibodies only are identified.
Related Papers (5)
The prevalence of antibodies to SARS-CoV-2 among blood donors in China.
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga,Ifedayo M. O. Adetifa,Ifedayo M. O. Adetifa,Henry K. Karanja,James Nyagwange,James Tuju,Perpetual Wanjiku,Rashid Aman,Mercy Mwangangi,Patrick Amoth,Kadondi Kasera,Wangari Ng’ang’a,Charles Rombo,Christine Yegon,Khamisi Kithi,Elizabeth Odhiambo,Thomas Rotich,Irene Orgut,Sammy Kihara,Mark Otiende,Christian Bottomley,Zonia N. Mupe,Eunice W. Kagucia,Katherine E. Gallagher,Katherine E. Gallagher,Anthony Etyang,Shirine Voller,Shirine Voller,John N. Gitonga,Daisy Mugo,Charles N. Agoti,Edward Otieno,Leonard Ndwiga,Teresa Lambe,Daniel B. Wright,Edwine Barasa,Benjamin Tsofa,Philip Bejon,Philip Bejon,Lynette Isabella Ochola-Oyier,Ambrose Agweyu,J. Anthony G. Scott,J. Anthony G. Scott,George M. Warimwe,George M. Warimwe +44 more
Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
Mars Stone,Clara Di Germanio,David J. Wright,Hasan Sulaeman,Honey Dave,Rebecca V. Fink,Edward P. Notari,Valerie Green,Donna Strauss,Debra Kessler,Mark Destree,Paula Saá,Phillip C. Williamson,Graham Simmons,Graham Simmons,Susan L. Stramer,Jean D. Opsomer,Jefferson M. Jones,Steven Kleinman,Michael P. Busch,Michael P. Busch +20 more
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.
Ifedayo M. O. Adetifa,Sophie Uyoga,John N. Gitonga,Daisy Mugo,Mark Otiende,James Nyagwange,Henry K. Karanja,James Tuju,Perpetual Wanjiku,Rashid Aman,Mercy Mwangangi,Patrick Amoth,Kadondi Kasera,Wangari Ng’ang’a,Charles Rombo,Christine Yegon,Khamisi Kithi,Elizabeth Odhiambo,Thomas Rotich,Irene Orgut,Sammy Kihara,Christian Bottomley,Eunice W. Kagucia,Katherine E. Gallagher,Katherine E. Gallagher,Anthony Etyang,Shirine Voller,Shirine Voller,Teresa Lambe,Daniel B. Wright,Edwine Barasa,Benjamin Tsofa,Philip Bejon,Philip Bejon,Lynette Isabella Ochola-Oyier,Ambrose Agweyu,J. Anthony G. Scott,J. Anthony G. Scott,J. Anthony G. Scott,George M. Warimwe,George M. Warimwe +40 more